@MayoClinic
  @MayoClinic
Mayo Clinic | Cardiac Amyloidosis No longer rare and untreatable - Bell-Ezziddine @MayoClinic | Uploaded September 2024 | Updated October 2024, 6 days ago.
Guest: Omar F. Abou Ezzeddine, M.D., M.S.
Hosts: Malcolm R. Bell, M.D.
 
Transthyretin amyloid cardiomyopathy (ATTR-CM), once considered rare, is more prevalent than previously thought. Diagnosing ATTR-CM is particularly important because there are now highly effective, specific therapies for ATTR-CM. In this podcast, we will provide a contemporary review of the diagnostic and therapeutic approach to patients with ATTR-CM in the current era.
 
Topics Discussed:

• When to suspect the disease & who to screen for ATTR-CM?
• How to diagnose and prognosticate ATTR-CM in the current era?
• Provide an overview of current and emerging therapies for managing ATTR-CM.

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services

Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!

No CME credit offered for this episode.
Cardiac Amyloidosis No longer rare and untreatable - Bell-Ezziddine3D Visualization of the Heart in Immersive Technology Like Mixed RealityTumor microenvironment and implications for vestibular schwannoma careNurse AnesthetistHow Immunotherapy Targets Melanoma SourceTowards the Development of an Antisense Oligonucleotide ASO for ADLD | ADLD Series, 2024Mayo Clinic Nephrology Fellowship (Minnesota)Entrevista a Nicole Landa, Coordinadora de Participación Comunitaria en Mayo Clinic FloridaMayo Clinic Minute - Who is at risk for a brain aneurysm?Robotics for Head and Neck CancerThe Discovery of REM Sleep - Season Three - Episode 4Larynx Transplant Research - Center for Regenerative Biotherapeutics

Cardiac Amyloidosis No longer rare and untreatable - Bell-Ezziddine @MayoClinic

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER